Fibclot (Human Fibrinogen)

Human Fibrinogen (Fibclot) is a clotting factor used to manage bleeding disorders. This intravenous medication supports blood coagulation, crucial for surgical or trauma-related bleeding. Learn more about its uses and effects.

Human Fibrinogen, marketed as Fibclot, is primarily used to control bleeding in individuals with congenital fibrinogen deficiency. It is often administered intravenously to support blood clotting during surgical procedures or in cases of trauma. This medication is designed to help manage bleeding episodes by replenishing fibrinogen levels in the bloodstream.

When administered, Human Fibrinogen works to enhance the blood's ability to clot, which can help reduce bleeding time. Common effects may include localized reactions at the injection site, such as redness or swelling. Some individuals might experience mild systemic reactions, but these are generally rare.

Human Fibrinogen should be used with caution in individuals with a history of allergic reactions to blood products. It is important to inform your healthcare provider about any existing medical conditions or medications you are taking. Always follow the prescribed dosage and administration guidelines to minimize potential risks.

Human Fibrinogen may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is advisable to consult with a healthcare professional before combining it with other treatments. Additionally, avoid using it with products known to cause allergic reactions in sensitive individuals.